HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint

Oncogene

Volumn 27, Issue 24, 2008, Pages 3457-3464

  Kim, S ^a   Park, S Y ^a   Yong, H ^a   Famulski, J K ^b   Chae, S ^a   Lee, J H ^a   Kang, C M ^c   Saya, H ^d   Chan, G K ^b   Cho, H ^a  

^a Ajou University School of Medicine   (South Korea)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Korea Institute of Radiation and Medical Science   (South Korea)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BubR1; Chromosome instability; HBV X; Mitotic checkpoint

Indexed keywords

ANAPHASE PROMOTING COMPLEX; BUB1 RELATED PROTEIN; CELL CYCLE PROTEIN 20; HEPATITIS B VIRUS X PROTEIN; MUTANT PROTEIN;

ARTICLE; CENTROMERE; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; CHROMOSOMES, HUMAN; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; KINETOCHORES; LIVER NEOPLASMS; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; PROTEIN-SERINE-THREONINE KINASES; SACCHAROMYCES CEREVISIAE; TRANS-ACTIVATORS; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

HEPATITIS B VIRUS;

EID: 44449120297     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210998     Document Type: Article

References (30)

1. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A et al. (2004). BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36: 744-749.
2. Chan GK, Jablonski SA, Sudakin V, Hittle JC, Yen TJ. (1999). Human BUBR1 is a mitotic checkpoint kinase that monitors CENP-E functions at kinetochores and binds the cyclosome/APC. J Cell Biol 146: 941-954.
3. Chan GK, Schaar BT, Yen TJ. (1998). Characterization of the kinetochore binding domain of CENP-E reveals interactions with the kinetochore proteins CENP-F and hBUBR1. J Cell Biol 143: 49-63.
4. Cleveland DW, Mao Y, Sullivan KF. (2003). Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell 112: 407-421.
5. Cotsiki M, Lock RL, Cheng Y, Williams GL, Zhao J, Perera D et al. (2004). Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. Proc Natl Acad Sci USA 101: 947-952.
6. Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S et al. (2004). Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res 64: 440-445.
7. Fang G. (2002). Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex. Mol Biol Cell 13: 755-766.
8. Fang G, Yu H, Kirschner MW. (1998). The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev 12: 1871-1883.
9. Forgues M, Difilippantonio MJ, Linke SP, Ried T, Nagashima K, Feden J et al. (2003). Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol Cell Biol 23: 5282-5292.
10. Fujii R, Zhu C, Wen Y, Marusawa H, Bailly-Maitre B, Matsuzawa S et al. (2006). HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res 66: 9099-9107.
11. Gollin SM. (2004). Chromosomal instability. Curr Opin Oncol 16: 25-31.
12. Henderson AS, Ripley S, Hino O, Rogler CE. (1988). Identification of a chromosomal aberration associated with a hepatitis B DNA integration site in human cells. Cancer Genet Cytogenet 30: 269-275.
13. Jin DY, Spencer F, Jeang KT. (1998). Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93: 81-91.
14. Kim S, Kim HY, Lee S, Kim SW, Sohn S, Kim K et al. (2007). Hepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and Dynein-dependent manners. J Virol 81: 1714-1726.
15. Kops GJ, Foltz DR, Cleveland DW. (2004). Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc Natl Acad Sci USA 101: 8699-8704.
16. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F et al. (2001). Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 120: 1763-1773.
17. Lee S, Tarn C, Wang WH, Chen S, Hullinger RL, Andrisani OM. (2002). Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines. J Biol Chem 277: 8730-8740.
18. Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S. (1997). The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res 57: 5137-5142.
19. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W et al. (2002). Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 99: 1978-1983.
20. Liu B, Hong S, Tang Z, Yu H, Giam CZ. (2005). HTLV-I Tax directly binds the Cdc20-associated anaphase-promoting complex and activates it ahead of schedule. Proc Natl Acad Sci USA 102: 63-68.
21. Madden CR, Slagle BL. (2001). Stimulation of cellular proliferation by hepatitis B virus X protein. Dis Markers 17: 153-157.
22. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W et al. (2001). MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409: 355-359.
23. Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM. (1980). Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 77: 1627-1631.
24. Murakami S. (2001). Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 36: 651-660.
25. Sen S. (2000). Aneuploidy and cancer. Curr Opin Oncol 12: 82-88.
26. Sudakin V, Chan GK, Yen TJ. (2001). Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154: 925-936.
27. Tang Z, Bharadwaj R, Li B, Yu H. (2001). Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. Dev Cell 1: 227-237.
28. Wang Q, Liu T, Fang Y, Xie S, Huang X, Mahmood R et al. (2004). BUBR1 deficiency results in abnormal megakaryopoiesis. Blood 103: 1278-1285.
29. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. (2007). Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11: 25-36.
30. Yun C, Cho H, Kim SJ, Lee JH, Park SY, Chan GK et al. (2004). Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulatedk inase-mitogen-activated protein pathway. Mol Cancer Res 2: 159-169.